Search

Search Constraints

You searched for: Author/Creator Anderson, Kenneth

Search Results

1. Accelerating anticancer drug development — opportunities and trade-offs. Issue 12 (December 2018)

4. Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients. (13th October 2020)

5. Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth. (5th July 2017)

7. Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma. Issue 12 (December 2018)

8. Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study. Issue 5 (May 2020)

10. Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. (23rd October 2020)